April 25, 2013 / 6:21 AM / 4 years ago

Novozymes Q1 core profit misses forecasts as costs rise

COPENHAGEN, April 25 (Reuters) - Danish industrial enzymes producer Novozymes' reported a smaller-than-expected rise in first quarter operating profit, capped by currency headwinds and acquisition costs.

The group kept its operating profit outlook for 2013 unchanged at growth of 4 to 7 percent and profit margins exceeding 24 percent, but cut its sales outlook slightly in Danish crowns.

Earnings before interest and tax (EBIT) rose to 709 million Danish crowns ($123.58 million) in January-March, below analysts' average estimate in a Reuters' poll for a rise to 717 million. ($1 = 5.7374 Danish crowns) (Reporting by Copenhagen newsroom. Editing by Jane Merriman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below